Year |
Citation |
Score |
2021 |
Vaught DB, Merkel AR, Lynch CC, Edwards J, Tantawy MN, Hilliard T, Wang S, Peterson T, Johnson RW, Sterling JA, Brantley-Sieders D. EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease. Jbmr Plus. 5: e10465. PMID 33869989 DOI: 10.1002/jbm4.10465 |
0.486 |
|
2018 |
Clément-Demange L, Mulcrone PL, Tabarestani TQ, Sterling JA, Elefteriou F. β2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1β and selectin-dependent manner. Journal of Bone Oncology. 13: 1-10. PMID 30245970 DOI: 10.1016/J.Jbo.2018.09.002 |
0.365 |
|
2018 |
Buenrostro D, Kwakwa KA, Putnam NE, Merkel AR, Johnson JR, Cassat JE, Sterling JA. Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner. Bone. PMID 29753718 DOI: 10.1016/J.Bone.2018.05.008 |
0.42 |
|
2017 |
Kwakwa KA, Sterling JA. Integrin αvβ3 Signaling in Tumor-Induced Bone Disease. Cancers. 9. PMID 28698458 DOI: 10.3390/cancers9070084 |
0.437 |
|
2017 |
Mulcrone PL, Campbell JP, Clément-Demange L, Anbinder AL, Merkel AR, Brekken RA, Sterling JA, Elefteriou F. Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-angiogenic Switch. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28300321 DOI: 10.1002/Jbmr.3133 |
0.399 |
|
2016 |
Wright LE, Ottewell PD, Rucci N, Peyruchaud O, Pagnotti GM, Chiechi A, Buijs JT, Sterling JA. Murine models of breast cancer bone metastasis. Bonekey Reports. 5: 804. PMID 27867497 DOI: 10.1038/bonekey.2016.31 |
0.419 |
|
2016 |
Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, Merkel AR, Johnson JR, Sterling JA, Wu JY, Giaccia AJ. Erratum: Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nature Cell Biology. 18: 1260. PMID 27784904 DOI: 10.1038/ncb3433 |
0.403 |
|
2016 |
Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, Merkel AR, Johnson JR, Sterling JA, Wu JY, Giaccia AJ. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nature Cell Biology. PMID 27642788 DOI: 10.1038/Ncb3408 |
0.436 |
|
2016 |
Nyman JS, Merkel AR, Uppuganti S, Nayak B, Rowland B, Makowski AJ, Oyajobi BO, Sterling JA. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease. Bone. PMID 27423464 DOI: 10.1016/J.Bone.2016.07.007 |
0.346 |
|
2016 |
Buenrostro D, Mulcrone PL, Owens P, Sterling JA. The Bone Microenvironment: a Fertile Soil for Tumor Growth. Current Osteoporosis Reports. PMID 27255469 DOI: 10.1007/s11914-016-0315-2 |
0.308 |
|
2016 |
Mulcrone PL, Campbell JP, Anbinder AL, Sterling JA, Elefteriou F. Abstract 2682: Sympathetic activation alters the bone vasculature: implication for osteotropic breast cancer metastasis Cancer Research. 76: 2682-2682. DOI: 10.1158/1538-7445.Am2016-2682 |
0.408 |
|
2015 |
Cannonier SA, Sterling JA. The Role of Hedgehog Signaling in Tumor Induced Bone Disease. Cancers. 7: 1658-83. PMID 26343726 DOI: 10.3390/cancers7030856 |
0.391 |
|
2015 |
Page JM, Merkel AR, Ruppender NS, Guo R, Dadwal UC, Cannonier S, Basu S, Guelcher SA, Sterling JA. Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growth. Data in Brief. 4: 440-6. PMID 26306316 DOI: 10.1016/J.Dib.2015.07.003 |
0.471 |
|
2015 |
Page JM, Merkel AR, Ruppender NS, Guo R, Dadwal UC, Cannonier SA, Basu S, Guelcher SA, Sterling JA. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II. Biomaterials. 64: 33-44. PMID 26115412 DOI: 10.1016/J.Biomaterials.2015.06.026 |
0.405 |
|
2015 |
Sterling JA. Addressing the controversy: do bisphosphonates directly affect primary tumors? Cancer Discovery. 5: 14-5. PMID 25583797 DOI: 10.1158/2159-8290.CD-14-1380 |
0.381 |
|
2015 |
Buenrostro D, Dadwal U, Guelcher S, Sterling J. Abstract 3191: The role of rigidity in myeloid-tumor cell interactions in bone Cancer Research. 75: 3191-3191. DOI: 10.1158/1538-7445.Am2015-3191 |
0.451 |
|
2015 |
Page JM, Merkel AR, Ruppender NS, Guo R, Dadwal UC, Cannonier S, Basu S, Guelcher SA, Sterling JA. Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growth Data in Brief. 4: 440-446. DOI: 10.1016/j.dib.2015.07.003 |
0.443 |
|
2014 |
Johnson RW, Merkel AR, Page JM, Ruppender NS, Guelcher SA, Sterling JA. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer. Clinical & Experimental Metastasis. 31: 945-59. PMID 25359619 DOI: 10.1007/S10585-014-9682-1 |
0.433 |
|
2014 |
Buenrostro D, Park SI, Sterling JA. Dissecting the role of bone marrow stromal cells on bone metastases. Biomed Research International. 2014: 875305. PMID 25054153 DOI: 10.1155/2014/875305 |
0.357 |
|
2014 |
Seeley EH, Wilson KJ, Yankeelov TE, Johnson RW, Gore JC, Caprioli RM, Matrisian LM, Sterling JA. Co-registration of multi-modality imaging allows for comprehensive analysis of tumor-induced bone disease. Bone. 61: 208-16. PMID 24487126 DOI: 10.1016/J.Bone.2014.01.017 |
0.336 |
|
2014 |
Hansen AG, Arnold SA, Jiang M, Palmer TD, Ketova T, Merkel A, Pickup M, Samaras S, Shyr Y, Moses HL, Hayward SW, Sterling JA, Zijlstra A. ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone. Cancer Research. 74: 1404-15. PMID 24385212 DOI: 10.1158/0008-5472.Can-13-1296 |
0.367 |
|
2013 |
Jin R, Sterling JA, Edwards JR, DeGraff DJ, Lee C, Park SI, Matusik RJ. Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone. Plos One. 8: e60983. PMID 23577181 DOI: 10.1371/Journal.Pone.0060983 |
0.322 |
|
2012 |
Danilin S, Merkel AR, Johnson JR, Johnson RW, Edwards JR, Sterling JA. Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction. Oncoimmunology. 1: 1484-1494. PMID 23264895 DOI: 10.4161/onci.21990 |
0.471 |
|
2012 |
Campbell JP, Merkel AR, Masood-Campbell SK, Elefteriou F, Sterling JA. Models of bone metastasis. Journal of Visualized Experiments : Jove. e4260. PMID 22972196 DOI: 10.3791/4260 |
0.417 |
|
2012 |
Campbell JP, Karolak MR, Ma Y, Perrien DS, Masood-Campbell SK, Penner NL, Munoz SA, Zijlstra A, Yang X, Sterling JA, Elefteriou F. Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. Plos Biology. 10: e1001363. PMID 22815651 DOI: 10.1371/Journal.Pbio.1001363 |
0.389 |
|
2012 |
Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM, Bhowmick NA. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Molecular Cancer Research : McR. 10: 494-503. PMID 22290877 DOI: 10.1158/1541-7786.Mcr-11-0506 |
0.31 |
|
2012 |
Bi X, Sterling JA, Perrien D, Merkel A, Nyman J, Rowland B, Mahadevan-Jansen A. Assessment of breast cancer induced bone quality changes using raman spectroscopy Biomedical Optics, Biomed 2012. |
0.305 |
|
2011 |
Biswas S, Nyman JS, Alvarez J, Chakrabarti A, Ayres A, Sterling J, Edwards J, Rana T, Johnson R, Perrien DS, Lonning S, Shyr Y, Matrisian LM, Mundy GR. Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. Plos One. 6: e27090. PMID 22096521 DOI: 10.1371/Journal.Pone.0027090 |
0.405 |
|
2011 |
Johnson RW, Merkel AR, Danilin S, Nguyen MP, Mundy GR, Sterling JA. 6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2. Anticancer Research. 31: 2705-12. PMID 21868511 |
0.375 |
|
2011 |
Guelcher SA, Sterling JA. Contribution of bone tissue modulus to breast cancer metastasis to bone. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 4: 247-59. PMID 21789687 DOI: 10.1007/S12307-011-0078-3 |
0.472 |
|
2011 |
Sterling JA, Guelcher SA. Bone structural components regulating sites of tumor metastasis. Current Osteoporosis Reports. 9: 89-95. PMID 21424744 DOI: 10.1007/S11914-011-0052-5 |
0.472 |
|
2011 |
Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Research. 71: 822-31. PMID 21189326 DOI: 10.1158/0008-5472.Can-10-2993 |
0.568 |
|
2011 |
Johnson LC, Johnson RW, Munoz SA, Mundy GR, Peterson TE, Sterling JA. Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction. Bone. 48: 141-51. PMID 20685406 DOI: 10.1016/j.bone.2010.05.033 |
0.347 |
|
2011 |
Sterling JA, Edwards JR, Martin TJ, Mundy GR. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone. 48: 6-15. PMID 20643235 DOI: 10.1016/j.bone.2010.07.015 |
0.369 |
|
2011 |
Ruppender N, Sterling* J, Martin T, Mundy G, Guelcher S. Skeletal rigidity enhances TGF-Β effects on cancer cell expression of osteolytic factors Bone. 48: S39. DOI: 10.1016/J.Bone.2010.10.109 |
0.344 |
|
2010 |
Ruppender NS, Merkel AR, Martin TJ, Mundy GR, Sterling JA, Guelcher SA. Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells. Plos One. 5: e15451. PMID 21085597 DOI: 10.1371/Journal.Pone.0015451 |
0.503 |
|
2010 |
Shaw AK, Johnson R, Sterling J, Mundy G, Moses H. Abstract 1956: A novel mouse model of breast cancer metastasis to bone Cancer Research. 70: 1956-1956. DOI: 10.1158/1538-7445.Am10-1956 |
0.49 |
|
2010 |
Li X, Sterling JA, Banerjee J, Munoz S, Mundy GR, Bhowmick NA. Abstract 1418: Stromal cells of prostate, not the bone marrow, facilitate prostate cancer osteoblastic tumor growth in bone Cancer Research. 70: 1418-1418. DOI: 10.1158/1538-7445.Am10-1418 |
0.332 |
|
2010 |
Edwards JR, Fowler J, Ruppender N, Sterling J, Lwin S, Johnson J, Edwards C, Mundy G. Breast cancer, melanoma and myeloma cells induce generalized bone loss Bone. 47. DOI: 10.1016/J.Bone.2010.04.125 |
0.396 |
|
2008 |
Sterling J, Johnson R, Roberts A, Li X, Bhowmick N, Mundy G. P35. Wnt signaling regulates Gli2 expression in human breast cancer cells that cause osteolysis Cancer Treatment Reviews. 34: 26-27. DOI: 10.1016/J.Ctrv.2008.03.077 |
0.419 |
|
2006 |
Sterling JA, Oyajobi BO, Grubbs B, Padalecki SS, Munoz SA, Gupta A, Story B, Zhao M, Mundy GR. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells. Cancer Research. 66: 7548-53. PMID 16885353 DOI: 10.1158/0008-5472.CAN-06-0452 |
0.572 |
|
Show low-probability matches. |